Laboratory Workup for Foot Paresthesia with History of Normocytic Anemia
Order vitamin B12 level, methylmalonic acid (MMA), complete blood count with peripheral smear, reticulocyte count, serum ferritin, and transferrin saturation immediately—this presentation strongly suggests B12 deficiency causing both the anemia and neuropathy, which can become irreversible if not treated promptly.
Primary Concern: Vitamin B12 Deficiency
The combination of normocytic anemia and paresthesia is a classic presentation for vitamin B12 deficiency, which can cause irreversible neurological damage if diagnosis is delayed 1, 2. Critically, neurological symptoms often precede or occur without hematologic abnormalities 2, 3. The normocytic anemia noted 6 months ago may represent early B12 deficiency before progression to macrocytosis, or the patient may have concurrent conditions masking the typical macrocytic picture 3.
Essential Initial Labs:
- Vitamin B12 level: This is the first-line test, though normal levels don't exclude deficiency 2
- Methylmalonic acid (MMA): More sensitive than B12 alone for detecting tissue deficiency 4, 2
- Homocysteine: Additional metabolic marker if MMA unavailable 2
- Complete blood count (CBC): Reassess the anemia and look for macrocytosis or pancytopenia 4
- Peripheral blood smear: Look for hypersegmented neutrophils (>5 lobes), which indicate megaloblastic changes even before anemia develops 1, 5
Comprehensive Anemia Evaluation
Since normocytic anemia was present 6 months ago, a complete workup is warranted 4:
Core Tests:
- Reticulocyte count (corrected for anemia): Distinguishes between production defects versus hemolysis/blood loss 4, 5
- Serum ferritin: For males, <25 ng/mL indicates iron deficiency 4
- Transferrin saturation: More reliable than ferritin alone, especially if inflammation present 4
- Folate level: Deficiency causes similar hematologic and neurologic findings 4
Additional Tests Based on Initial Results:
- Lactate dehydrogenase (LDH) and indirect bilirubin: If hemolysis suspected (elevated in B12 deficiency due to intramedullary hemolysis) 1, 5
- Haptoglobin: Decreased in hemolysis 1, 5
- Intrinsic factor antibodies: If B12 deficiency confirmed, to diagnose pernicious anemia (though negative result doesn't exclude it) 1, 2
- Anti-parietal cell antibodies: Less specific but supportive 1, 2
Neurological Assessment Context
For the paresthesia specifically, the diabetes foot care guidelines 6 recommend screening for peripheral neuropathy, but given the anemia history, metabolic causes (B12, folate) must be ruled out first before attributing symptoms to diabetic neuropathy or other causes. The 10-g monofilament test mentioned in 6 is useful for diabetic neuropathy but won't identify the underlying cause in this case.
Critical Pitfalls to Avoid:
- Don't wait for macrocytosis: B12 deficiency can present with normocytic anemia, especially early or when combined with iron deficiency or thalassemia trait 3
- Don't rely on B12 level alone: Up to 50% of patients with neurological B12 deficiency have "normal" serum B12 levels 2
- Don't delay treatment: Neurological damage from B12 deficiency can become permanent within months 1, 2, 3
- Check MCV carefully: The mean corpuscular volume may be "masked normal" if concurrent iron deficiency exists 4
Renal Function Assessment
Given the normocytic anemia, also order creatinine and estimated GFR to evaluate for chronic kidney disease, which commonly causes normocytic anemia and would require different management 4, 7. The anemia of CKD guidelines [4-4] emphasize that normocytic anemia in CKD requires iron studies and assessment of erythropoietin deficiency.
Immediate Action Algorithm:
- Stat labs: B12, MMA, CBC with smear, reticulocyte count
- Same-day labs: Ferritin, transferrin saturation, folate, creatinine
- If B12 <200 pg/mL or MMA elevated: Start parenteral B12 replacement immediately—don't wait for antibody results 1, 3
- If B12 normal but high clinical suspicion: Check MMA and homocysteine; consider empiric trial of B12 if elevated 2
The case report 3 demonstrates how a decade of symptoms was missed because providers didn't connect normocytic anemia with neurological complaints—this exact scenario must be avoided by comprehensive testing now.